K.J. Harrison & Partners Inc Zymeworks Inc. Transaction History

K.J. Harrison & Partners Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 26, 2022	SELL	$15.19 - $29.33 $455,700 - $879,900	-30,000 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$27.35 - $37.28 $820,500 - $1.12 Million	30,000 New	30,000 $876,000
Q1 2021 May 14, 2021	SELL	$29.83 - $56.81 $2.68 Million - $5.11 Million	-90,000 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$39.12 - $54.99 $1.96 Million - $2.75 Million	50,000 Added 125.0%	90,000 $4.25 Million
Q3 2020 Nov 09, 2020	BUY	$29.21 - $46.58 $876,300 - $1.4 Million	30,000 Added 300.0%	40,000 $1.87 Million
Q3 2019 Oct 25, 2019	SELL	$22.78 - $29.08 $455,600 - $581,600	-20,000 Reduced 66.67%	10,000 $246,000
Q2 2019 Aug 05, 2019	BUY	$15.0 - $22.49 $225,000 - $337,350	15,000 Added 100.0%	30,000 $659,000
Q4 2018 Jan 24, 2019	BUY	$10.95 - $15.44 $32,850 - $46,320	3,000 Added 25.0%	15,000 $219,000
Q3 2018 Oct 26, 2018	BUY	$12.21 - $16.61 $146,520 - $199,320	12,000 New	12,000 $189,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $906M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

Stay updated on K.J. Harrison & Partners Inc with notifications on news.